A recent study has added to the growing list of health benefits associated with the Mediterranean diet, suggesting its potential role in preventing metabolic dysfunction-associated steatotic liver disease (MASLD).
The diet, which emphasises vegetables, olive oil, fish, and reduced intake of red meat and dairy, has shown early promise in addressing indicators linked to liver inflammation and function among MASLD patients.
According to Science Alert, citing findings published in the journal Nutrients, MASLD affects nearly one-third of the global population due to excessive fat accumulation in the liver. This condition may progress to chronic inflammation, fibrosis or, in severe cases, liver cancer. MASLD is also closely associated with obesity and type 2 diabetes.
The study, led by a research team at the University of Rovira i Virgili in Spain, reviewed 13 clinical studies involving 926 MASLD patients. It assessed the effects of the Mediterranean dietary pattern, alongside intermittent fasting strategies, on various health markers.
Findings revealed that the combined approach may support weight loss, improve blood glucose levels and reduce inflammation. Early indications of improved liver function were also noted. However, the researchers called for long-term studies to determine the sustained efficacy of these dietary interventions in managing MASLD.
Although data on liver-specific outcomes remain limited, current evidence suggests that the Mediterranean diet could serve as a supportive measure in preventing or mitigating MASLD.
The dietary pattern consists primarily of fruits, vegetables, whole grains, nuts, olive oil, fish and poultry, with a reduced intake of processed foods, sugars and red meat. Its previously established benefits for general health and chronic disease prevention are reinforced by these new findings, adding a potential role in liver health.
